American biotechnology company working on synthetic biopolymers that protect and repair soft tissue. Its platform mimics the glycosaminoglycan layer that lines mucosal surfaces, and its lead product GLX-100 is being developed as a treatment instilled into the bladder for interstitial cystitis and bladder pain syndrome, with further work on other soft tissue indications.
No hay comentarios disponibles.
Deja tu valoración & comentario